title: Prominent adverse effects of thalidomide in primary Sjögren's syndrome.
authors.forename: Stanley R
authors.initials: SR
authors.lastname: Pillemer
authors.forename: Rose Anne
authors.initials: RA
authors.lastname: Leakan
authors.forename: Vidya
authors.initials: V
authors.lastname: Sankar
authors.forename: Joan
authors.initials: J
authors.lastname: Manny
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Baum
authors.forename: Janine
authors.initials: J
authors.lastname: Smith
authors.forename: Usha
authors.initials: U
authors.lastname: Chaudhry
authors.forename: Philip C
authors.initials: PC
authors.lastname: Fox
authors.forename: Lida
authors.initials: L
authors.lastname: Radfar
authors.forename: Sophie
authors.initials: S
authors.lastname: Ligier
authors.forename: Michael T
authors.initials: MT
authors.lastname: Brennan
mesh_terms: D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide